NZ Respiratory & Sleep Institute
Auckland, New Zealand
Hospital in Auckland
Ascot Office Park 93-95 Ascot Avenue, Greenlane East, Auckland 1051
About NZ Respiratory & Sleep Institute
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
4
Fisher and Paykel Healthcare
1
Galapagos NV
1
Genentech, Inc.
1
Grifols Therapeutics LLC
1
Pliant Therapeutics, Inc.
1
Clinical Trials at NZ Respiratory & Sleep Institute
During the past decade, NZ Respiratory & Sleep Institute conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on
average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Lebrikizumab in Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
2013-07-31
2017-01-02
Completed
1,081
Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD)
2013-11-01
2026-06-01
Recruiting
339
A Study of Lebrikizumab (RO5490255) in Participants With Severe Oral Corticosteroids (OCS) Dependent Asthma
2014-02-28
2016-12-20
Completed
230
A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care
2018-11-05
2021-03-30
Terminated
781
Evaluation of Efficacy and Safety of PLN-74809 in Patients With Idiopathic Pulmonary Fibrosis
2020-03-03
2023-03-30
Active, not recruiting
120
A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis
2021-03-19
2023-02-10
Completed
665
A Study to Evaluate Long Term Safety and Efficacy of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis
2021-08-30
2023-02-10
Terminated
117
Physiological Study to Compare Noninvasive Ventilation (NIV) Masks
2021-07-07
2022-05-01
Enrolling by invitation
40
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "NZ Respiratory & Sleep Institute" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Fisher and Paykel Healthcare" with 1 trials
sponsored, "Galapagos NV" with 1 trials sponsored, "Genentech, Inc." with 1 trials sponsored and "Grifols Therapeutics LLC"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
Clinical Trials Conditions at NZ Respiratory & Sleep Institute
According to Clinical.Site data, the most researched conditions in "NZ Respiratory & Sleep Institute" are
"Idiopathic Pulmonary Fibrosis" (4 trials), "Asthma" (2 trials), "Chronic Obstructive Pulmonary Disease" (1 trials), "Hypercapnia" (1 trials) and "Pulmonary Emphysema in Alpha-1 PI Deficiency" (1 trials). Many other conditions were trialed in "NZ Respiratory & Sleep Institute" in a lesser frequency.
Clinical Trials Intervention Types at NZ Respiratory & Sleep Institute
Most popular intervention types in "NZ Respiratory & Sleep Institute" are "Drug" (7 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Lebrikizumab" (2 trials), "PRM-151 (Zinpentraxin Alfa)" (2 trials), "0.9% Sodium Chloride for Injection, USP" (1 trials) and "Alpha-1 MP" (1 trials). Other intervention names were less common.
Clinical Trials Genders at NZ Respiratory & Sleep Institute
The vast majority of trials in "NZ Respiratory & Sleep Institute" are
9 trials for "All" genders.
Clinical Trials Status at NZ Respiratory & Sleep Institute
Currently, there are NaN active trials in "NZ Respiratory & Sleep Institute".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 3 completed trials in NZ Respiratory & Sleep Institute,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in NZ Respiratory & Sleep Institute, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".